Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Biological Analysis of MABs in NHL in a Translational Prospective Observational Study Within Italian Clinical Practice

NCT07767799

Conditions
B-Cell Non-Hodgkin Lymphoma (NHL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Ematologia - Fondazione del Piemonte per l'Oncologia - IRCCS Candiolo, Torino, Italy
  • Oncoematologia IOV - Ospedale di Castelfranco Veneto Castelfranco Veneto, Treviso, Italy
  • SCDU Ematologia -AOU SS. Antonio e Biagio e Cesare Arrigo di Alessandria Alessandria, Italy
  • Divisione di Oncologia e dei Tumori immuno-correlati - IRCCS Centro di Riferimento Oncologico di Aviano Aviano, Italy
View all 20 locations
View Trial Details
Not yet recruiting

A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

NCT06970496

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, China
  • Jiangxi Cancer Hospital Nanchang, China
  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China
View Trial Details
Not yet recruiting

A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis

NCT07765524

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations
  • The Frist Affiliated Hospital of Jinan University Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • The Frist Affiliated Hospital of Guangxi Medical university Nanning, Guangxi, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Not yet recruiting

R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma

NCT07764601

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • The First People's Hospital of Changzhou Changzhou, Jiangsu, China
  • The First People's Hospital of Huai'an Huai'an, Jiangsu, China
  • The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
  • Wuxi People's Hospital Wuxi, Jiangsu, China
View Trial Details

Related conditions